Semglee is a medicine used to treat diabetes in patients from 2 years of age. It contains the active substance insulin glargine. Semglee is a ‘biosimilar medicine’. This means that Semglee is highly similar to another biological medicine (the ‘reference medicine’) that is already authorised in the EU.
Therapeutic Indication
Treatment of diabetes mellitus in adults, adolescents and children aged 2 years and above.
Therapeutic Area (MeSH)
ATC Code
A10AE04
ATC Item
N/A
Pharmacotherapeutic Group
Drugs used in diabetes
Active Substance (Summary)
INN / Common Names
EMA Name
Semglee
Medicine Name
Semglee
Aliases
N/ANo risk management plan link.
